TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
NVO

Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

38.20$ -0.2% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Cash Flow

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 55,199 million DKK. Tick rows to compare them in a chart.

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Cash Flow NVO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
15,189 11,153 12,098 10,117 12,921 6,032 9,815 15,770 11,619 7,412 9,890 15,039 16,688 5,165 10,012 24,261 17,506 172 11,255 25,255 21,507 -3,017 23,586 23,961 24,239 7,101 29,814 28,577 40,966 9,551 14,314 50,503 43,850 12,301 24,591 40,785 46,107 7,619 24,084 55,199 133,009
736 1,116 708 863 706 905 732 768 783 1,642 1,058 1,110 2,095 195 1,086 1,158 2,130 902 1,377 1,217 1,349 1,368 1,650 1,636 2,041 2,035 1,719 2,177 2,525 2,992 2,914 8,845 2,150 5,198 3,830 4,833 7,757 5,562 3,536 10,304 27,159
3,344 368 -3,519 -1,264 -459 292 -4,349 -1,135 -794 414 -4,511 -617 -827 363 -4,597 -487 -1,763 823 -5,968 -1,882 -722 1,040 – – – 1,539 – -4,544 -3,278 2,149 – – – – – – – – – – –
– 10,904 1,324 896 2,598 3,802 -382 824 386 0.0 515 5,232 2,677 -1,663 4,525 5,445 4,999 -6,079 -1,619 9,050 7,746 -4,589 5,833 4,918 18,803 -7,409 18,497 10,987 4,294 – – – – – – – – – – – –
-2,401 -190 -90 -1,593 -153 -1,798 644 -617 -690 -2,707 -2,128 -898 1,722 -1,686 -7,496 7,033 79 -3,328 -1,126 2,865 293 -13,841 1,893 4,089 -11,010 -308 -10,216 -4,015 11,669 -9,683 -9,608 9,857 -11,263 13,603 -16,428 4,755 -4,960 20,370 -33,231 13,319 -4,502
2,605 2,765 1,712 1,702 2,003 3,231 2,958 2,559 2,912 3,981 3,037 2,779 2,447 1,907 1,723 1,367 6,086 1,518 1,499 1,884 1,688 2,049 1,780 2,575 4,225 6,173 4,801 7,035 10,624 16,436 9,009 13,238 12,504 16,558 14,586 16,275 15,415 43,837 12,039 12,801 84,092
-2,677 -2,731 -692 -725 -1,991 -3,163 -2,574 -2,543 -2,864 -4,099 -3,026 -2,833 -2,441 -3,209 -2,106 -1,367 -6,063 -12,900 -3,481 -2,886 -4,635 -20,603 -1,907 -4,200 -4,961 -24,918 -6,647 -9,285 -29,175 -14,717 3,956 -20,731 -20,904 -91,216 -6,673 -14,248 -15,425 -42,812 -11,712 -12,764 -82,713
7,600 3,382 11,448 1,757 7,396 3,043 11,810 1,131 7,238 1.1 12,309 12,309 7,100 19,409 12,551 12,551 7,570 20,121 13,495 1.0 8,021 21,517 15,690 15,690 9,613 25,303 18,337 18,337 13,430 0.2 28,557 0.0 15,583 44,140 35,274 174 16,663 257 35,312 0.0 52,232
-3,599 -4,095 -4,245 -3,760 -4,238 -4,602 -4,334 -3,416 -3,571 -4,246 -2,949 -4,580 -2,875 -4,930 -2,690 -5,521 -2,984 -5,660 -2,960 -5,440 -3,535 -7,512 -4,477 -7,450 -4,620 -7,539 -5,199 -8,823 -6,141 -9,761 -2,836 -7,449 -2,405 -7,491 -1,388 -41 -47 -6.9 -2,400 -3,499 -5,953
– 94 – – – 94 16 15 15 0.0 -357 -76 -37 -271 -420 -8.0 -140 5,300 -349 3,934 -175 12,061 -1,705 -244 -330 -129 -478 -373 -261 – – – -413 44,326 15,331 -19,622 -433 29,467 14,745 -7,340 36,439
-11,199 -4,095 -13,725 -5,728 -11,634 -4,602 -14,137 -5,423 -10,809 -4,152 -13,525 -6,746 -10,012 -5,201 -13,509 -7,681 -10,694 -360 -14,475 -3,836 -11,731 4,549 -19,135 -10,431 -14,563 -7,668 -20,621 -12,589 -19,832 -10,116 -26,382 16,683 -18,401 36,835 5,451 -46,230 -17,096 29,467 -17,433 -19,132 -24,194
1,320 4,380 -2,311 3,494 -771 -1,715 -6,873 7,862 -2,083 -435 -6,583 5,400 4,310 -3,345 -5,698 15,138 614 -13,239 -6,547 18,548 5,263 -18,771 2,489 9,548 5,158 -15,261 2,283 6,638 8,309 -15,491 -8,068 46,497 4,197 -41,363 23,283 -20,503 13,649 -5,620 -5,337 23,355 26,047
12,584 8,388 10,386 8,415 10,918 2,801 6,857 13,211 8,707 3,431 6,853 12,260 14,241 3,258 8,289 22,894 11,420 -1,346 9,756 23,371 19,819 -5,066 21,806 21,386 20,014 928 25,013 21,542 30,342 -6,885 5,305 37,265 31,346 -4,257 10,005 24,510 30,692 -36,218 12,045 42,398 48,917

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?